[ Price : $8.95]
FDA warns Beacon Hill Medical Pharmacy about CGMP and other violations in its production of compounded drugs.[ Price : $8.95]
FDA issues a guideline on mitigation measures to support Class 2 classification for nucleic acid-based in vitro diagnostic devices...[ Price : $8.95]
FDA posts a draft guidance on Migraine: Developing Drugs for Acute Treatment that is intended to assist sponsors in their migraine...[ Price : $8.95]
Covidien begins a Class 1 recall of its Medi-Trace Cadence and Kendall Defibrillation Electrodes because they do not work with Phi...[ Price : $8.95]
FDAs Cincinnati District Office warns Western Enterprises/Scott Fetzer Company about QS violations in its manufacturing of medical...[ Price : $8.95]
FDA releases a final guidance on Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection that def...[ Price : $8.95]
Omeros Corp. suspends Huntingtons disease trials involving OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, as it fur...[ Price : $8.95]
FDA issues a letter of support for further exploration of two kidney biomarkers identified and evaluated by a Critical Path Instit...